Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate (Q40638371)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 1999
edit
Language Label Description Also known as
English
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate
scientific article published on June 1999

    Statements

    Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate (English)
    Sievers EL
    Spielberger RT
    Forman SJ
    Flowers D
    Smith FO
    Shannon-Dorcy K
    Berger MS
    Bernstein ID
    1 June 1999
    3678-3684

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit